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Unlike other orthopaedic fields, the disease encountered in
the field of musculoskeletal oncology can be life-threat-
ening. It is therefore necessary for orthopaedic oncologists
to have a sound grasp of their discipline, and to have skill
and expertise when managing their patients. In recent
years, there has been a tendency for patients with muscu-
loskeletal sarcomas to be treated at specialist clinics, and
therefore orthopaedic general practitioners have fewer
opportunities to gain experience in musculoskeletal
oncology. However, it is extremely likely that patients with
a serious sarcoma will first visit a local clinic and consult a
general practitioner. Therefore it is obvious that the prog-
nosis of such patients would be significantly affected by the
initial responses of the general practitioner they consult.
Against this background, the main theme for the 45th
Annual Musculoskeletal Tumor Meeting of the Japanese
Orthopaedic Association in 2012 is ‘‘Reconfirmation of
basic knowlege of orthopaedic oncology – The importance
of a good working relationship between general practitio-
ners and specialists’’.
In the last 40 years, the clinical outcomes for muscu-
loskeletal sarcoma have markedly improved due to the
establishment of neoadjuvant chemotherapy and the
development of surgical techniques based on imaging
modalities such as CT and MRI. For example, the current
5-year survival rate for patients with osteosarcoma is
60–80% in comparison with 10–15% in 1970. Furthermore,
in the light of studies focusing on the surgical margin, a
concept that has undergone remarkable development in
Japan, orthopaedic oncology specialists now recommended
that musculoskeletal sarcomas should be excised with an
adequate safety margin. Currently, Limb salvage proce-
dures are indicated for more than 80% of patients under-
going surgery for musculoskeletal sarcomas. However,
over the last 20 years, the potentially favorable outcome in
the majority of such patients has not been realized. In my
view, clinical outcomes for patients with musculoskeletal
sarcomas in the extremities are still less than satisfactory.
Strict assessment of the acquired surgical margin of
excised tumors is undoubtedly an innovation that origi-
nated in Japan. According to the new guideline for safety
margins based on difference in tumor malignancy stipu-
lated by the Surgical Society for the Musculoskeletal Sar-
coma in 2010, the current safety margins are 2 cm or more
for high-grade sarcoma and 1 cm or more for low-grade
sarcoma. Moreover, those based on the response to pre-
operative chemotherapy are classified as marginal or more
for marked responders, 2 cm or more for partial respond-
ers, and 5 cm or more for poor responders. Although the
safety margins for lesions with skip and lymph node
metastasis are still unresolved, a serial trial to minimize the
safety margin seems to have nearly achieved its goal.
Prosthetic replacement for reconstruction after resection
of musculoskeletal sarcomas has shown marked progress
with the modular type of prosthesis. Use of a metal pros-
thesis is undoubtedly one of the main methods for recon-
struction of massive bone and joint defects. Further minor
changes in model or better new materials for prosthesis
manufacture, such as the Howmedica Modular Resection
System (HMRS) and the Global Modular Resection System
(GMRS), are expected in the future. However, it is rec-
ognized that biological reconstruction achieves better long-
term function than a prosthesis. As well as the surgical
margin, prosthetic replacement also seems to have nearly
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achieved its goal. Therefore, new innovative treatments
might be necessary to achieve improvements in outcome.
Carbon ion radiotherapy is a specialized radiation
technique for patients with unresectable bone and soft tis-
sue sarcomas located in the spine or pelvis. Due to
equipment limitations, it has been indicated strictly for
tumors not exceeding 15 cm in diameter. However, in
contrast to data obtained initially, local recurrence in the
area neighboring the irradiated field has often been
observed recently. Therefore, I think there is a need to re-
examine the current data for carbon ion radiotherapy.
Finally, I would like to deal with the issue of clinical
problems that can occur after an initial unplanned resection
of a soft tissue sarcoma. If this problem can be resolved,
further improvements in the outcome of patients with soft
tissue sarcomas might be expected. Initial unplanned
resections of soft tissue sarcomas have not decreased in
number, despite a campaign aimed at general practitioners
and, also surgeons working in other fields. An unplanned
resection procedure is classified as a simple marginal or
intralesional resection of a soft tissue sarcoma without
consideration of the tumor’s malignancy or the need for
subsequent radical resection. After an initial unplanned
resection, the operative field shows wider tumor contami-
nation than before. Therefore, ablative surgery such as
amputation or disarticulation of the affected limb is often
necessary instead of limb salvage. Alternatively, wider
massive reconstruction involving vessel transplantation or
microsurgical reconstruction may be needed. Oncology
specialists are sufficiently aware that immediate additional
wide resection yields better results than simple observation
until postoperative local recurrence. Numerous reports
have already addressed the clinical problems that can occur
after such unplanned resection [1–3], and patients in this
unfortunate position are often referred to our clinic.
Although, for a long time, oncologists have strenuously
advised against unplanned resections as well as calling for
general practitioners to be better educated or trained, there
are still many patients presenting with soft tissue sarcomas
after initial unplanned resection.
Giving due considerations to the current situations, 20
educational lectures covering basic knowledge of ortho-
paedic oncology for non-specialists are planned for the
45th Annual Musculoskeletal Tumor Meeting in 2012. I
also intend to cover this theme, i.e., the dangers of
unplanned resection, in the lecture I will present as
Congress President. Based on the clinical data collected
during a 5-year period between April 2007 and March 2012
in our clinic, I will present a statistical analysis of onco-
logical outcomes, operative damage and limb function in
patients who have undergone unplanned resection in
comparison with untreated patients. Several problem cases
will be introduced, including a patient with leiomyosar-
coma in the abdominal wall, who was referred to us more
than 6 months after unplanned resection, and developed
local recurrence in the neighboring area one year after
additional wide resection due to the fact that imaging of
postoperative tumor contamination was indistinct. Fortu-
nately, the patient remains free of any evident disease after
postoperative chemotherapy 3 years after an additional
resection procedure. In another patient with pleomorphic
liposarcoma in the thigh, reconstruction of the femoral
artery and vein was necessary. Another patient with
malignant fibrous histiocytoma in the subcutis of the lower
leg underwent an unavoidable above / knee amputation due
to widely spread post-biopsy hematoma. Moreover, a
patient with a malignant peripheral nerve sheath tumor in
the chest wall showed multiple extra-pulmonary metastases
despite excellent local control after additional resection.
Obviously, therefore, any unplanned resection for soft tis-
sue sarcoma is extremely inadvisable as a means of tumor
control, especially for high-grade sarcomas.
Although this problem may remain with us for a long
time, oncology specialists must make every practical effort
to prevent any inadvised unplanned resections by general
practitioners. I sincerely hope that our discussions at the
Meeting will bear fruit, and serve to discourage unplanned
resection for soft tissue sarcomas.
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